How Psilocybin Affects the Brain: An Overview of the Science
Psilocybin has recently become the focus of much scientific interest. This is due to its potential therapeutic effects for various mental health conditions, including depression and anxiety. But how does this psychoactive substance interact with our brains? In this article, we will explore the neurochemical effects of psilocybin, its role in modulating emotional processing and cognition, and its potential neuroprotective effects.
The Neurochemical Effects of Psilocybin
Psilocybin can have a profound effect on the brain. It is a prodrug, which means it changes into another chemical called psilocin in the body. This chemical is the one responsible for the psychotropic effects or the change in perceptions and thoughts that psilocybin causes.
When consumed, psilocybin affects different parts of the brain by binding to certain receptors, particularly the 5-HT1A, 5-HT2A, and 5-HT2C receptors [1]. These receptors are located on brain cells called neurons. When psilocybin attaches to these receptors, it causes an increase in the levels of a chemical called serotonin in the brain. This increase in serotonin leads to changes in the way brain cells communicate with each other, and this causes changes in perception, thoughts, and consciousness.
The Role of Serotonin Receptors in Psilocybin's Effects on the Brain
Serotonin receptors are proteins located on neurons that bind to serotonin molecules and activate or inhibit neuronal activity depending on which receptor type is activated. When psilocybin attaches to these receptors, it causes complex changes in the brain's activity that can result in altered states of consciousness. As mentioned previously, the 5-HT1A and 5-HT2A are particularly important in psilocybin's effects on the brain.
Activation of 5-HT1A receptors decreases the activity of neurons, and 5-HT2A receptors increase the activity of neurons [2]. This leads to a complex interplay of activity and inactivation of neurons that results in the psychoactive effects of psilocybin.
The Impact of Psilocybin on Brain Function and Neuroplasticity
Psilocybin has been shown to have an impact on brain function by influencing both structural and functional changes within certain brain regions.
Structural changes include increased gray matter volume within certain cortical regions associated with emotion regulation as well as increased connectivity between these regions [3]. Functional changes include increased regional homogeneity (a measure of how similar or different parts are) within certain brain regions involved with emotion processing and cognitive control. These findings suggest that psilocybin may be able to alter brain function through neuroplasticity (the ability of the brain to reorganize itself).
The Role of Psilocybin in Modulating Emotional Processing and Cognition
Research suggests that psilocybin may be able to modulate emotional processing and cognition through its influence on particular neurotransmitter systems such as serotonin and dopamine. For example, studies have shown that psilocybin can reduce rumination (repetitive thinking about negative experiences) by decreasing activity within certain areas associated with self-referential processing (thinking about oneself). It has also been shown to improve cognitive flexibility (the ability to switch between tasks quickly) by increasing dopamine levels within certain areas associated with executive functioning (planning and decision-making) [4].
The Potential Neuroprotective Effects of Psilocybin
In addition to its potential therapeutic benefits for mental health conditions such as depression and anxiety, research also suggests that it may be able to protect against neuron degeneration due to its influence on autophagy pathways which could potentially help protect against age-related diseases such as Alzheimer's disease or Parkinson's disease.[5]
Overall, this overview highlights the intricate and intriguing interactions between psilocybin and the brain, bringing us closer to unlocking the potential therapeutic benefits of this psychoactive substance for mental health conditions. While more research is needed, these findings offer promising insights and pave the way for further study.
At Psychly, we are committed to upholding the highest standards in our content creation process. We strive to ensure that all statements presented in our articles are supported by reliable, high-quality sources, such as peer-reviewed studies and reputable academic journals.
- The Psychly Team
- I. Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, J. Javier Meana, & Ortega, J. A. (2022). Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response. 154, 113612–113612. https://doi.org/10.1016/j.biopha.2022.113612
- Celada, P., Puig, M., Amargós-Bosch, M., Adell, A., & Artigas, F. (2004). The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. Journal of psychiatry & neuroscience : JPN, 29(4), 252–265.
- Smausz, R., Neill, J., & Gigg, J. (2022). Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology. Journal of psychopharmacology (Oxford, England), 36(7), 781–793. https://doi.org/10.1177/02698811221092508
- Barba, T., Buehler, S., Kettner, H., Radu, C., Cunha, B. G., Nutt, D. J., Erritzoe, D., Roseman, L., & Carhart-Harris, R. (2022). Effects of psilocybin versus escitalopram on rumination and thought suppression in depression. BJPsych open, 8(5), e163. https://doi.org/10.1192/bjo.2022.565
- Vann Jones, S. A., & O'Kelly, A. (2020). Psychedelics as a Treatment for Alzheimer's Disease Dementia. Frontiers in synaptic neuroscience, 12, 34. https://doi.org/10.3389/fnsyn.2020.00034